A 68-year-old man with poorly controlled diabetes mellitus presents with severe pain and a vesicular rash in the V1 distribution (ophthalmic division of trigeminal nerve) for 2 days. Examination reveals vesicles on the forehead and upper eyelid; the cornea appears clear. What is the most appropriate immediate next step?

Explanation

## Clinical Scenario Analysis This patient has **herpes zoster ophthalmicus (HZO)** — a medical emergency: - V1 (ophthalmic) dermatome involvement - Age >60 years with comorbidity (diabetes) - Early presentation (2 days) - Risk of sight-threatening complications ### Key Point: **Herpes zoster ophthalmicus requires IV acyclovir and urgent ophthalmology referral** to prevent keratitis, uveitis, and vision loss. ## Why IV Acyclovir Is Mandatory ### High-Yield: V1 zoster carries a **40–50% risk of ocular involvement** (keratitis, anterior uveitis, scleritis, post-herpetic neuralgia of the eye). IV acyclovir achieves higher intraocular and corneal concentrations than oral therapy. | Feature | Oral Acyclovir | IV Acyclovir | |---------|----------------|-------------| | **Indication** | Localized zoster (trunk, limbs) | HZO, disseminated zoster, immunocompromised | | **Dose** | 800 mg 5× daily | 10–15 mg/kg every 8 hours | | **Corneal penetration** | Suboptimal | Excellent | | **CNS penetration** | Poor | Good | ## Management Protocol ```mermaid flowchart TD A[Herpes Zoster Ophthalmicus]:::outcome --> B[IV Acyclovir 10-15 mg/kg Q8H]:::action A --> C[Urgent Ophthalmology Referral]:::action B --> D[Slit-lamp examination]:::action D --> E{Anterior uveitis?}:::decision E -->|Yes| F[Add topical corticosteroids + cycloplegics]:::action E -->|No| G[Supportive care + analgesics]:::action C --> H[Monitor for keratitis, scleritis]:::action ``` ### Clinical Pearl: - **Hutchinson's sign** (vesicles on the tip or side of the nose) indicates high risk of ocular involvement and mandates ophthalmology review - Even if the cornea is currently clear, anterior uveitis can develop within days - Elderly patients and those with diabetes have worse outcomes and higher PHN risk ## Adjunctive Measures 1. **Topical care**: Lubricating drops; avoid topical antivirals (poor penetration) 2. **Analgesics**: Gabapentin or pregabalin for neuropathic pain 3. **Systemic corticosteroids**: Controversial; may be considered in select cases to reduce PHN (not first-line) ### Warning: Do NOT use oral acyclovir alone for HZO — inadequate corneal and intraocular drug levels increase risk of sight-threatening complications.